Hartman Institute for Therapeutic Organ Regeneration

Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.

TitleInborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.
Publication TypeJournal Article
Year of Publication2023
AuthorsLee D, Le Pen J, Yatim A, Dong B, Aquino Y, Ogishi M, Pescarmona R, Talouarn E, Rinchai D, Zhang P et al.
Corporate AuthorsCoV-Contact Cohort§, COVID Human Genetic Effort¶
JournalScience
Volume379
Issue6632
Paginationeabo3627
Date Published2023 Feb 10
ISSN1095-9203
KeywordsChild, COVID-19, Cytokines, Endoribonucleases, Humans, RNA, Double-Stranded, SARS-CoV-2, Systemic Inflammatory Response Syndrome
Abstract

<p>Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that follows benign COVID-19. We report autosomal recessive deficiencies of , , or in five unrelated children with MIS-C. The cytosolic double-stranded RNA (dsRNA)-sensing OAS1 and OAS2 generate 2'-5'-linked oligoadenylates (2-5A) that activate the single-stranded RNA-degrading ribonuclease L (RNase L). Monocytic cell lines and primary myeloid cells with OAS1, OAS2, or RNase L deficiencies produce excessive amounts of inflammatory cytokines upon dsRNA or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulation. Exogenous 2-5A suppresses cytokine production in OAS1-deficient but not RNase L-deficient cells. Cytokine production in RNase L-deficient cells is impaired by MDA5 or RIG-I deficiency and abolished by mitochondrial antiviral-signaling protein (MAVS) deficiency. Recessive OAS-RNase L deficiencies in these patients unleash the production of SARS-CoV-2-triggered, MAVS-mediated inflammatory cytokines by mononuclear phagocytes, thereby underlying MIS-C.</p>

DOI10.1126/science.abo3627
Alternate JournalScience
PubMed ID36538032
PubMed Central IDPMC10451000
Grant ListR01 AI127372 / AI / NIAID NIH HHS / United States
UM1 HG006504 / HG / NHGRI NIH HHS / United States
R01 AI091707 / AI / NIAID NIH HHS / United States
R01 AI104887 / AI / NIAID NIH HHS / United States
S10 OD018521 / OD / NIH HHS / United States
ZIA AI001270 / ImNIH / Intramural NIH HHS / United States
R01 AI088364 / AI / NIAID NIH HHS / United States
MR/S032304/1 / MRC_ / Medical Research Council / United Kingdom
R01 AI130345 / AI / NIAID NIH HHS / United States
U19 AI111825 / AI / NIAID NIH HHS / United States
U24 HG008956 / HG / NHGRI NIH HHS / United States
/ HHMI / Howard Hughes Medical Institute / United States
UL1 TR001866 / TR / NCATS NIH HHS / United States
R01 AI161444 / AI / NIAID NIH HHS / United States
F99 CA274708 / CA / NCI NIH HHS / United States
P01 AI138938 / AI / NIAID NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
R21 AI160576 / AI / NIAID NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065